RecruitingNCT07029256

Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)

Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder

Sponsor

Mayo Clinic

Enrollment

100 participants

Start Date

Jul 26, 2024

Study Type

OBSERVATIONAL

Conditions

Bladder Urothelial Carcinoma

Summary

This study is being done to test the feasibility and accuracy of using an ultrasound-guided core needle biopsy technique as a potential tool for staging urothelial carcinoma of the bladder (UCB).

Eligibility

Min Age: 18 Years

Inclusion Criteria2

Undergoing radical cystectomy for confirmed or suspected urothelial carcinoma of the bladder
Prior abdominal imaging

Exclusion Criteria1

History of partial cystectomy or complex bladder reconstruction or substitution (i.e. bladder augment or urothelial recurrence in a neobladder)

Interventions

OTHERNon-Interventional Study

Non-interventional study

Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07029256

Related Trials

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

NCT062631533 locations

Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers

NCT052965641 location

Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL)

NCT045749602 locations

Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct)

NCT064163192 locations

Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.

NCT061673561 location